Public trial registry of the CCC-Munich

Trial AFLIBC06097

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AFLIBC06097
World
Full title
:

A Multicenter, Single arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients with Metastatic Colorectal Cancer (mCRC) Previously Treated with an Oxaliplatin-Containing Regimen

World
EudraCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C19 Bösartige Neubildung am Rektosigmoid, Übergang
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Positive
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
2
Participants
Function Prename Surname Organization
World Responsible contact Volker Heinemann KUM - Med3 - Medizinische Klinik und Poliklinik III Magnifier
World Principal Investigator Volker Heinemann KUM - Med3 - Medizinische Klinik und Poliklinik III Magnifier
World Sponsor Magnifier